GOVX

#5175
GeoVax Labs, Inc. New
1.3400 USD
+4.69%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
1.3400
1.3400
Faixa anual
1.1368
1.9900
Mudança diária
+4.69%
Mudança mensal
-23.86%
Mudança em 6 meses
-7.59%
Mudança anual
-7.59%
Fechamento anterior
1.2800
Abrir
1.3400
Bid
Ask
Mínimo
1.3400
High
1.3400
Volume
1
Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
  • Market Capitalization 1.5922 M
  • Employee 17
  • Founded 1988
  • CEO David A. Dodd
  • Website www.geovax.com
  • Headquarter Delaware, United States
  • FIGI BBG000BGGJD8
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.51
Price to sales ratio
3.24

GeoVax Labs Inc

GeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax's development platform uses Modified Vaccinia Ankara vector technology, with improvements to antigen design and manufacturing capabilities. GeoVax uses recombinant DNA or recombinant viruses to produce virus-like particles in the person being vaccinated.

Notícias